# Investigating Sex-Linked miRNAs for Potential Osteoarthritis Therapy Biomarkers

**Authors:** Viviana Costa, Giulia Sacchi, Luca Andriolo, Giuseppe Filardo, Gianluca Giavaresi, Francesca Veronesi

PMC · DOI: 10.3390/ijms27021019 · 2026-01-20

## TL;DR

This study explores sex-linked microRNAs in osteoarthritis, identifying seven miRNAs that differ between men and women and may influence disease progression.

## Contribution

The study identifies seven sex-specific miRNAs and their potential targets in early osteoarthritis, offering new insights into sex-based differences in OA.

## Key findings

- Seven miRNAs were significantly upregulated in men compared to women with knee osteoarthritis.
- The miRNAs are associated with ACLY and PIK3R1, which are linked to OA-related pathways and metabolism.
- Sex-specific miRNA expression may influence OA progression through effects on inflammation and catabolic gene expression.

## Abstract

Sex-specific factors can influence the onset and progression of osteoarthritis (OA), yet the molecular mechanisms underlying their impact remain poorly defined. This study investigated whether plasma microRNAs (miRNAs) correlate to sex-dependent OA progression, based on evidence of enhanced spontaneous osteoclastogenesis in peripheral blood mononuclear cells (PBMCs) derived from OA patients. miRNAs were evaluated on OA-plasma (n = 20 men, 20 women with knee OA; KL grade I–II) and their role on OA signaling was investigated through bioinformatic analysis. Seven miRNAs were identified as significantly upregulated in men’ vs. women’ samples: hsa-miR-107, hsa-miR-23a-3p, hsa-miR-103a-3p, hsa-let-7g-5p, hsa-miR-22-3p, hsa-miR-106a-5p, hsa-miR-142-3p, and were associated with OA-related tissues and pathways. Notably, two common targets were identified: Adenosine Triphosphate Citrate Lyase (ACLY), a key enzyme linking citrate metabolism to epigenetic regulation, and phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1), a component of the phosphatidylinositol-3-kinase PI3K/AKT/mTOR pathway. In men, increased miRNA expression may repress ACLY and PIK3R1, affecting catabolic gene expression, inflammation, and OA progression. Conversely, their lower expression in women may mitigate these effects by counterbalancing the OA-promoting influences driven by sex hormones. A functional validation is needed to confirm miRNA–ACLY/PIK3R1 interactions and their sex-specific roles in early OA pathophysiology.

## Linked entities

- **Genes:** ACLY (ATP citrate lyase) [NCBI Gene 47], PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295]
- **Diseases:** osteoarthritis (MONDO:0005178)

## Full-text entities

- **Genes:** ACLY (ATP citrate lyase) [NCBI Gene 47] {aka ACL, ATPCL, CLATP}, MIR223 (microRNA 223) [NCBI Gene 407008] {aka MIRN223, miRNA223, mir-223}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, KL (klotho) [NCBI Gene 9365] {aka HFTC3, KLA}, MIR107 (microRNA 107) [NCBI Gene 406901] {aka MIRN107, miR-107}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** inflammation (MESH:D007249), knee OA (MESH:D020370), OA (MESH:D010003)
- **Chemicals:** citrate (MESH:D019343)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12842146/full.md

---
Source: https://tomesphere.com/paper/PMC12842146